Loading...
Reach Banner
Keywords
Last name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Victor Blanchette and Manuel Carcao.

 
Connection Strength
 
 
 
7.589
 
  1. Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS. IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. Blood Adv. 2020 04 14; 4(7):1492-1500.
    View in: PubMed
    Score: 0.901
  2. Carcao M, Zunino L, Young NL, Dover S, Bouskill V, Hilliard P, Price VE, Blanchette VS. Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT tool. Haemophilia. 2020 Jan; 26(1):73-78.
    View in: PubMed
    Score: 0.881
  3. Carcao MD, Chelle P, Clarke E, Kim L, Tiseo L, Morfini M, Hossain T, Rand ML, Brown C, Edginton AN, Lillicrap D, Iorio A, Blanchette VS. Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference? J Thromb Haemost. 2019 07; 17(7):1085-1096.
    View in: PubMed
    Score: 0.848
  4. Carcao M, Kearney S, Santagostino E, Oyesiku JOO, Young NL, Meunier J, Hoxer CS, Zhang C, Blanchette VS. Insight into health-related quality of life of young children with haemophilia B treated with long-acting nonacog beta pegol recombinant factor IX. Haemophilia. 2017 05; 23(3):e222-e224.
    View in: PubMed
    Score: 0.729
  5. Blanchette VS, Carcao M. Childhood acute immune thrombocytopenic purpura: 20 years later. Semin Thromb Hemost. 2003 Dec; 29(6):605-17.
    View in: PubMed
    Score: 0.290
  6. Carcao MD, Connolly BL, Chait P, Stain AM, Acebes M, Massicotte P, Blanchette VS. Central venous catheter-related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors. Haemophilia. 2003 Sep; 9(5):578-83.
    View in: PubMed
    Score: 0.285
  7. Blanchette VS, Zunino L, Grassmann V, Barnes C, Carcao MD, Curtin J, Jackson S, Khoo L, Komrska V, Lillicrap D, Morfini M, Romanova G, Stephens D, Zapotocka E, Rand ML, Blatny J. A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects. Thromb Haemost. 2021 Oct; 121(10):1326-1336.
    View in: PubMed
    Score: 0.238
  8. Blanchette V, Carcao M. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol. 2000 Jul; 37(3):299-314.
    View in: PubMed
    Score: 0.228
  9. Tole S, Dhir P, Pugi J, Drury LJ, Butchart S, Fantauzzi M, Langer JC, Baker JM, Blanchette VS, Kirby-Allen M, Carcao MD. Genotype-phenotype correlation in children with hereditary spherocytosis. Br J Haematol. 2020 11; 191(3):486-496.
    View in: PubMed
    Score: 0.227
  10. Blanchette V, Carcao M. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Transfus Sci. 1998 Sep; 19(3):279-88.
    View in: PubMed
    Score: 0.201
  11. Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998 Jun; 424:71-4.
    View in: PubMed
    Score: 0.198
  12. Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon MC, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS. Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort. Lancet Haematol. 2018 Jun; 5(6):e252-e260.
    View in: PubMed
    Score: 0.197
  13. Al-Battat S, Rand ML, Bouskill V, Lau W, Blanchette VS, Kahr WHA, Rivard GE, Carcao MD. Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions. Br J Haematol. 2018 05; 181(3):410-413.
    View in: PubMed
    Score: 0.184
  14. Carcao MD, Avila L, Leissinger C, Blanchette VS, Aledort L. An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia. Haemophilia. 2017 09; 23(5):e444-e447.
    View in: PubMed
    Score: 0.183
  15. Carcao MD, Avila L, Leissinger C, Blanchette VS, Aledort L. An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia. Haemophilia. 2017 09; 23(5):e447-e450.
    View in: PubMed
    Score: 0.183
  16. Labarque V, Perinparajah V, Bouskill V, Stain AM, Wakefield C, Manuel C, Blanchette VS, James PD, Lillicrap D, Carcao MD. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A. Am J Hematol. 2017 06; 92(6):E94-E96.
    View in: PubMed
    Score: 0.183
  17. Labarque V, Stain AM, Blanchette V, Kahr WH, Carcao MD. Intracranial haemorrhage in von Willebrand disease: a report on six cases. Haemophilia. 2013 Jul; 19(4):602-6.
    View in: PubMed
    Score: 0.138
  18. Traivaree C, Blanchette V, Armstrong D, Floros G, Stain AM, Carcao MD. Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding. Haemophilia. 2007 Sep; 13(5):552-9.
    View in: PubMed
    Score: 0.094
  19. Barnes C, Blanchette V, Lillicrap D, Mann K, Stain AM, Leggo J, Hilliard P, Carcao M. Different clinical phenotype in triplets with haemophilia A. Haemophilia. 2007 Mar; 13(2):202-5.
    View in: PubMed
    Score: 0.091
  20. Carcao M, St Louis J, Poon MC, Grunebaum E, Lacroix S, Stain AM, Blanchette VS, Rivard GE. Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience. Haemophilia. 2006 Jan; 12(1):7-18.
    View in: PubMed
    Score: 0.084
  21. Barnes C, Blanchette V, Canning P, Carcao M. Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med. 2005 Apr; 15(2):145-50.
    View in: PubMed
    Score: 0.079
  22. Price VE, Carcao M, Connolly B, Chait P, Daneman A, Temple M, Stain AM, Sung L, Al-Tralbosi H, Blanchette VS. A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia. J Thromb Haemost. 2004 May; 2(5):737-42.
    View in: PubMed
    Score: 0.075
  23. Revel-Vilk S, Schmugge M, Carcao MD, Blanchette P, Rand ML, Blanchette VS. Desmopressin (DDAVP) responsiveness in children with von Willebrand disease. J Pediatr Hematol Oncol. 2003 Nov; 25(11):874-9.
    View in: PubMed
    Score: 0.072
  24. Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM, Brooker L, Carcao MD. Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost. 2003 Jun; 1(6):1228-36.
    View in: PubMed
    Score: 0.070
  25. Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br J Haematol. 2003 Jan; 120(1):135-41.
    View in: PubMed
    Score: 0.068
  26. Revel-Vilk S, Blanchette VS, Sparling C, Stain AM, Carcao MD. DDAVP challenge tests in boys with mild/moderate haemophilia A. Br J Haematol. 2002 Jun; 117(4):947-51.
    View in: PubMed
    Score: 0.065
  27. Carcao MD, Blanchette VS, Stephens D, He L, Wakefield CD, Butchart S, Christie DJ, Rand ML. Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100). Br J Haematol. 2002 Jun; 117(4):961-4.
    View in: PubMed
    Score: 0.065
  28. Sun HL, Yang M, Poon MC, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S. Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes. Haemophilia. 2021 Sep; 27(5):751-759.
    View in: PubMed
    Score: 0.061
  29. Goren R, Pullenayegum E, Blanchette VS, Dover S, Carcao M, Israels SJ, Chan A, Rivard GE, Steele M, Cloutier S, Klaassen RJ, Sinha R, Price VE, Laferriere N, Paradis E, Wu JK, Feldman BM. Patterns of joint damage in severe haemophilia A treated with prophylaxis. Haemophilia. 2021 Jul; 27(4):666-673.
    View in: PubMed
    Score: 0.061
  30. Dover S, Young NL, Blanchette VS, Klaassen RJ, Chan AK, Wakefield C, Bouskill V, Carcao M, Belletrutti M, Bruce AAK, Price VE. Measuring the impact of hemophilia on families: Development of the Hemophilia Family Impact Tool (H-FIT). Res Pract Thromb Haemost. 2021 May; 5(4):e12519.
    View in: PubMed
    Score: 0.061
  31. Price VE, Dover S, Blanchette VS, Klaassen RJ, Belletrutti M, Bruce AAK, Chan AK, Wakefield C, Carcao M, Bouskill V, Young NL. Updating the Canadian Hemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in the era of extended half-life clotting factor concentrates. Res Pract Thromb Haemost. 2021 Mar; 5(3):403-411.
    View in: PubMed
    Score: 0.060
  32. Swystun LL, Ogiwara K, Rawley O, Brown C, Georgescu I, Hopman W, Labarque V, Male C, Thom K, Blanchette VS, Carcao MD, Lillicrap D. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients. Blood. 2019 09 12; 134(11):880-891.
    View in: PubMed
    Score: 0.054
  33. Beck CE, Carcao M, Cada M, Porter S, Blanchette VS, Parkin PC. A Quality Improvement Bundle to Improve Informed Choice for Children With Typical, Newly Diagnosed Immune Thrombocytopenia. J Pediatr Hematol Oncol. 2018 11; 40(8):e537-e543.
    View in: PubMed
    Score: 0.051
  34. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, Sparling CR, Stephens D, Ryan G, Freedman J, Rand ML. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol. 1998 Apr; 101(1):70-3.
    View in: PubMed
    Score: 0.049
  35. Rand ML, Carcao MD, Blanchette VS. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting. Semin Thromb Hemost. 1998; 24(6):523-9.
    View in: PubMed
    Score: 0.048
  36. Carneiro JDA, Blanchette V, Ozelo MC, Antunes SV, Villaca PR, Young NL, Castro D, Brandão LR, Carcao M, Abad A, Feldman BM. Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia Study. Haemophilia. 2017 Sep; 23(5):682-688.
    View in: PubMed
    Score: 0.046
  37. Fischer K, Poonnoose P, Dunn AL, Babyn P, Manco-Johnson MJ, David JA, van der Net J, Feldman B, Berger K, Carcao M, de Kleijn P, Silva M, Hilliard P, Doria A, Srivastava A, Blanchette V. Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective. Haemophilia. 2017 Jan; 23(1):11-24.
    View in: PubMed
    Score: 0.044
  38. Crivianu-Gaita V, Rivard GE, Carcao M, Teitel J, St-Louis J, Blanchette V, Pullenayegum E, Abad A, Feldman BM. Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A. Haemophilia. 2016 Sep; 22(5):e401-5.
    View in: PubMed
    Score: 0.044
  39. Robertson JD, Yenson PR, Rand ML, Blanchette VS, Carcao MD, Notley C, Lillicrap D, James PD. Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease. J Thromb Haemost. 2011 Sep; 9(9):1752-60.
    View in: PubMed
    Score: 0.031
  40. Valentino LA, Carcao M, Mathew P, Leissinger CA, Berntorp E, Blanchette V, Escuriola-Ettingshausen C, Ewenstein B, Ewing N, Gringeri A, Hoots WK, Negrier C. The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report. Haemophilia. 2009 Jul; 15(4):959-65.
    View in: PubMed
    Score: 0.026
  41. Biss TT, Chan AK, Blanchette VS, Iwenofu LN, McLimont M, Carcao MD. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey. Haemophilia. 2008 Sep; 14(5):923-30.
    View in: PubMed
    Score: 0.025
  42. Ota S, Mclimont M, Carcao MD, Blanchette VS, Graham N, Paradis E, Feldman BM. Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study. Haemophilia. 2007 Jan; 13(1):12-20.
    View in: PubMed
    Score: 0.022
  43. Barnes C, Rivard GE, Poon MC, Teitel J, Pai M, Kern M, Blanchette VS, Carcao M. Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT. Haemophilia. 2006 Jan; 12(1):1-6.
    View in: PubMed
    Score: 0.021
  44. Berman J, Young N, Carcao M, Blanchette V, Ipp M. Hospitalization of children with acute immune thrombocytopenic purpura - is it necessary? Paediatr Child Health. 2002 Jul; 7(6):386-9.
    View in: PubMed
    Score: 0.016
  45. Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost. 2000 Sep; 84(3):401-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.